אינג'י 10 מג80 מג טבליות

Country: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

EZETIMIBE; SIMVASTATIN

Доступно од:

MERCK SHARP & DOHME ISRAEL LTD

АТЦ код:

C10AA01

Фармацеутски облик:

טבליה

Састав:

EZETIMIBE 10 MG; SIMVASTATIN 80 MG

Пут администрације:

פומי

Тип рецептора:

מרשם נדרש

Произведен од:

MERCK SHARP & DOHME (ITALIA) S.P.A.

Терапеутска група:

SIMVASTATIN

Терапеутска област:

SIMVASTATIN

Терапеутске индикације:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Датум одобрења:

2012-04-30